Hepatocellular carcinoma (HCC) is a common malignancy with poor clinical outcome, whose histogenesis is the subject of intense debate. Specifically, expression of cytokeratins (CKs) 7 and 19, associated with aggressive biological behaviour, is proposed to reflect a possible progenitor-cell origin or tumour de-differentiation towards a primitive phenotype. This work addresses that problem by studying CKs 7 and 19 expression in N-diethylnitrosamine (DEN)-induced mouse HCCs. ICR mice were divided into 6 DEN-exposed and 6 matched control groups. Samples were taken from each group at consecutive time points. Hyperplastic foci (13 lesions) occurred at 29 to 40 weeks (groups 8, 10 and 12) with diffuse dysplastic areas (19 lesions) and with one hepatocellular adenoma (HCA) (at 29 weeks). HCCs (4 lesions) were observed 40 weeks after the first DEN administration (group 12). CKs 7 and 19 showed identical expression patterns and located to large, mature hepatocytes, isolated or in small clusters. Hyperplastic foci and the single HCA were consistently negative for both markers while dysplastic areas and HCCs were positive. These results support the hypothesis that CKs 7 and 19 expression in hepatocellular malignancies result from a dedifferentiation process rather than from a possible progenitor cell origin.
Introduction
Liver cancer is a major public health problem, with approximately 748 000 new cases diagnosed yearly (Ferlay et al. 2010) . The majority of these cases are histologically classified as hepatocellular carcinomas (HCC) and occur mostly in older males in developing countries, due to the distribution of the risk factors (Motola-Kuba et al. 2006) . HCCs are believed to emerge through a process of multistep carcinogenesis, but their histogenesis is still a matter of discussion. One long-established view is that normal mature hepatocytes undergo neoplastic transformation to originate pre-malignant lesions and that early-stage HCCs arise within such lesions, giving then place to high-grade carcinomas, originating a characteristic nodule-within-nodule structure (Sakamoto et al. 1991) . However, it has also been hypothesized that a set of HCCs may originate from hepatic stem cells (Durnez et al. 2006 ; Lee et al. 2006 ). This hypothesis is supported by the expression patterns of several hepatic differentiation markers. Cytokeratins (CKs) 8 and 18 are equally expressed by hepatocytes and bile duct cells, while cytokeratin (CK) 7 and CK19 are considered as markers of cholangiocytic differentiation (Strnad et al. 2008) . Nevertheless, it has been observed that some HCCs express CKs 7 and 19, as well as c-kit that is a hepatic stem cell marker (Kim et al. 2004) , displaying an intermediate hepatocellular-cholangiocytic progenitor cell-like phenotype. Furthermore, expression of CK19 has been associated with poor prognosis (Uenishi et al. 2003; Ding et al. 2004; Durnez et al. 2006 ). However, Shibuya and collaborators (Shibuya et al. 2011) have recently put forward another contribution to this debate by proposing that malignant hepatocytes may trans-differentiate (or dedifferentiate) into immature stem cell-like cells. An experimental carcinogenesis experiment may be useful to address this problem, by studying the expression of differentiation markers over time and thus determining whether tumours result from the clonal expansion of progenitor cells or dedifferentiate to acquire a progenitor cell-like phenotype. Over the years, several experimental rodent models have been used to study the pathogenesis of HCC, particularly mice and rats (Heindryckx et al. 2009 ). Chemically-induced models using N-diethylnitrosamine (DEN) are long-established and among the most frequently used (Goldfarb et al. 1983) . DEN belongs to the N-nitroso group and is widely known for its ability to induce tumours in a multiplicity of organs, including the liver, the stomach, the lung and the haematopoietic organs. DEN is a genotoxic, DNA-alkylating carcinogen that requires metabolic activation (Hecht et al. 1989 ). The first biotransformation step is hydroxylation to -hydroxylnitrosamine, mediated by cytochrome P450, which shows its highest activity in centrilobular hepatocytes (Kang et al. 2007 ). Upon cleavage of acetaldehyde an ethyldiazonium ion is formed, reacting with DNA and other nucleophiles, including DNA repair enzymes. DEN-induced mouse tumours often harbour H-ras activating mutations (Stahl et al. 2005) . While activation of the Ras pathway is a common event in human hepatocarcinogenesis (Calvisi et al. 2006) , mutations of the Hras proto-oncogene itself are less frequent and associated with a more aggressive biological behaviour (Wang et al. 2001) . Accordingly, DEN-induced tumours are thought to closely mimic the more aggressive human HCCs.
The necessary development time after a single DEN administration for HCC depends on several factors, namely administered dose, administration route, age, sex and strain of the animals (Vesselinovitch & Mihailovich,1983; Vesselinovitch et al. 1984; Heindryckx et al. 2009 ). The present work employs a multiple dose DEN-induced mouse HCC model to study the expression of CKs 7 and 19 in pre-neoplastic and neoplastic hepatic lesions.
Materials and Methods

Animals and experimental conditions
One hundred and twenty male ICR mice with five weeks of age (Harlan, Barcelona) 
Experimental procedures
At six weeks of age, all mice were randomly divided into twelve groups. Animals from groups 1, 3, 5, 7, 9 and 11 (controls, CTL) were intraperitoneally injected with a saline solution weekly for eight consecutive weeks (administration route -i.p. once a week), whereas animals from groups 2, 4, 6, 8, 10 and 12 (exposed groups) received DEN (Sigma-Aldrich) at a dose of 35mg per Kg of body weight (Heindryckx et al., 2012) . Throughout the experimental protocol (Figure 1 ), animals were daily monitored for signs of distress. Food and water intake, as well as animal weights, were weekly recorded. Animals from groups 1 and 2, 3 and 4, 5 and 6, 7 and 8, 9 and 10 were euthanized at 8, 15, 22, 29 and 36 weeks (W) after the first administration of DEN, respectively, by means of a lethal dose of pentobarbital sodium, injected intraperitoneally. Euthanasia of animals from groups 11 (40W CTL) and 12 (40W exposed) was performed at 40 weeks after the DEN first administration, because some mice of the DEN-exposed group exhibited external signs of distress.
Sample collection and histological processing
A complete necropsy was carried out in all animals in order to check for tumoral masses. The liver, brain, heart, lungs, spleen, stomach, intestine, pancreas, kidneys, adrenal glands, testes, gastrocnemius muscles and a dorsal skin sample were collected into 10% neutral buffered formalin and fixated for 48 hours. Posteriorly the samples were routinely processed and paraffin-embedded.
Histological and immunohistochemical analysis
Histological sections (2µm-thick) were obtained and stained with haematoxylin and eosin (H&E) for examination on light microscopy. The presence of haemorrhage and other vascular disorders, bile cysts, necrosis, apoptosis, nuclear and cytoplasmic changes/accumulations were noted. Proliferative hepatic lesions were classified as hyperplastic foci, hepatocellular adenoma (HCA) or HCC (Deschl et al. 2001) . Furthermore, multifocal to regionally extensive, poorly-delimited dysplastic areas,
showing loss or distortion of lobular architecture, irregular hepatocyte plates, moderate cell atypia and mitotic activity were classified as diffuse dysplasia. Immunohistochemical detection of CK7 and CK19 was performed on 2µm-thick sections using a standard peroxidase protocol. Heat-induced antigen retrieval was performed employing citrate buffer in a microwave for 15 minutes. Monoclonal anti-CK7 (RCK105) and anti-CK19 (A-3) were acquired from Santa Cruz Biotechnology, diluted in phosphate-buffered saline (1:500) and incubated with the tissue sections for one hour at room temperature. Immunoreactivity was detected using diaminobenzidine. Negative controls were obtained by omitting the primary antibody. Bile duct epithelial cells were used as positive internal controls.
Statistical analysis
Data were expressed as mean±standard deviation (SD) and compared by one -way analysis of variance (ANOVA) followed by Tukey's multiple comparison test at the 5% significant level (p<0.05). All tests were performed using the GraphPad Prism, version 5.01 (GraphPad Software, Inc., La Jolla, CA, USA).
Results
The mortality rate in the DEN group during the experimental protocol was 6.67% (4 out of 60 animals, one in group 2, another in group 10 and two in group 12). Despite the enrichment of cage environment, male competitive behaviour was noticed, resulting in punctual injuries and focal loss of hair (barbering behavior).
Regarding animal growth, the ponderal homogeneity index (iPH) and ponderal gain (PG) for control and DEN-exposed groups were calculated (Table 1) . Drinking-water consumption was lower in DEN-treated animals compared with control groups (not significant). Food intake was also lower in DEN-exposed groups. Statistically significant differences between groups were noticed during the assay at 29 and 36 weeks after the first DEN exposure, regarding final body weight (p<0.05).
Control animals ( was observed in the biliary epithelium and hepatocytes surrounding necrotic areas, in both exposed and control animals.
Nodular hepatic lesions occurred from twenty-nine weeks after the first DEN administration and were often visible macroscopically (Figure 2 ). The first hyperplastic foci were observed in group 8 (29W exposed). Such foci were clearly delimited from the adjacent parenchyma, were composed of tight hepatocellular plates which compressed the hepatic sinusoids and showed distinct, basophilic or mixed type, cytoplasmic coloration ( Figure 4d ). Four out of 10 animals (40%) showed hepatic hyperplastic foci (six nodules, Table 2 ). One animal showing 2 hyperplastic foci also exhibited dysplastic changes in a distant and poorly-delimited area classified as diffuse dysplasia (10%) Four out of 8 (50%) animals from group 12 (40W exposed) exhibited large hepatic, soft, grey to light brown or occasionally haemorrhagic nodules, measuring up to 1.0 cm in diameter. Histologically, these nodules were classified as HCCs. These lesions arose within diffuse dysplastic areas and showed invasive growth and a multifocal distribution. HCCs ( Figure 4f ) were composed of moderately to highly pleomorphic cells disposed in solid nests, trabeculae or, multifocally, pseudoacinar structures, supported by a loose fibrovascular stroma. Neoplastic cells showed moderate nuclear pleomorphism, a prominent nucleolus and up to four mitotic figures per high power field.
Cells varied in size, were often vacuolated and frequently assumed a signet-ring morphology.
Multifocally, variably sized intracytoplasmic hyaline bodies were present. Scattered cells or cell groups exhibiting moderate to strong cytoplasmic immunostaining for CK7 and CK19 were present (Figures 5f and 6f) . Immunopositive hepatocytes were mostly large, little-or non-vacuolated cells, with vacuolated cells showing a fainter immunostaining. Immunostaining for both CKs was consistently present in the same areas. Groups of erythroblasts were present in all HCCs and were larger than those observed in dysplastic areas. In one instance, fully-differentiated bone marrow developed inside a carcinomatous nodule, with myeloid, erythroid, lymphoid and platelet precursors distributed between bone lamellae and adipocytes ( Figure 3f ). All animals from group 12 (40W exposed) showed diffuse dysplastic areas (8 out of 8 animals, 100%) and 3 out 8 (37.5%) showed hyperplastic foci (4 lesions in total). The immunostaining patterns observed in these lesions were identical to those observed in previous groups.
Discussion
The histogenesis of HCC is the subject of an intense debate. In fact, since some tumour subtypes show different biological behaviour, refining their histopathological classification has important consequences for patient treatment and prognosis (Ding et al. 2004; Durnez et al. 2006) . HCCs with a progenitor cell-like phenotype express certain characteristic markers of cholangiocytes (Ding et al. 2004; Durnez et al. 2006) . While CKs 8 and 18 are expressed by both hepatocytes and epithelial bile duct cells, CK7 and CK19 are used as markers of cholangiocytic differentiation (Strnad et al. 2008 ).
In the present work, the expression of CKs 7 and 19 was studied in a murine model of chemical hepatocarcinogenesis, in non-neoplastic, pre-neoplastic and neoplastic tissues.
Immunopositive cells were not observed in control tissues in the early exposed groups, apart from bile duct epithelial cells and hepatocytes bordering necrotic foci. These were not small, scattered cells resembling hepatic progenitor cells but a continuous lining of large, mature hepatocytes. It seems likely that these hepatocytes are responding to liver damage and have suffered corresponding cytoskeletal rearrangements involving CKs 7 and 19 expression -a similar phenomenon was previously described in alcoholic steatohepatitis and cholestatic liver diseases (Vaneyken et al. 1989; Zatloukal et al. 2004 ). Activation of hepatic progenitor cells in the early stages following DEN exposure was not detected immunohistochemically. Hyperplastic foci are considered early preneoplastic changes in the process of multi-step hepatocarcinogenesis. Overexpression of CKs 8 and 18 has been described in hyperplastic foci in DEN-exposed RasH2, B6C3F1 and C57BL/6 mice (Kakehashi et al. 2010; Kawai et al. 2010; Kushida et al. 2011 ). These authors agree that CKs 8 and 18-positive foci seem to be reliable markers for pre-malignant lesions in those mouse strains.
Expression of CK19 has also been recently described in DEN-induced hyperplastic foci (especially in eosinophilic foci) and HCAs in C57BL/6 mice (Kushida et al. 2011) . Andersen et al. (Anderson et al. 2010 ) also associated CK19 expression with malignancy and with malignant progression of preneoplastic liver lesions in a rat model.
In the present study, immunopostivity for CKs 7 and 19 was always coincident and distributed in small cell clusters or isolated cells, in a pattern resembling that described by Shibuya et al. (Shibuya et al. 2011) and not forming nodules as described by Kushida et al. (Kushida et al. 2011) . However, in contrast with these last author's findings, hyperplastic nodules were consistently negative for both CK7 and CK 19. This discrepancy must be regarded with caution due to the low number of hyperplastic foci detected in the present study and the fact that these were basophilic or mixed instead of eosinophilic. On the other hand, immunopositive hepatocytes were found outside hyperplastic foci, Table 2 -Histological incidence of hyperplastic foci, dysplastic lesions, hepatocellular adenomas and carcinomas, and CK7/CK9 immunoexpression among DEN-exposed and control ICR mice. 
